Literature DB >> 15305340

A comprehensive characterization of the peptide and protein constituents of human seminal fluid.

Kim Y C Fung1, L Michael Glode, Spencer Green, Mark W Duncan.   

Abstract

BACKGROUND: Knowledge of the peptide and protein components of seminal fluid and their role in prostate diseases including benign prostatic hyperplasia and prostate carcinoma is scant. We have undertaken a proteomic analysis of semen as a forerunner to identifying sensitive and specific diagnostic markers of prostatic diseases; to aid in improved therapeutic intervention; and, to enhance our understanding of prostate health and disease.
METHODS: Peptide and protein components of pooled human seminal fluid (n = 5) were separated by gel electrophoresis (1D and 2D) and identified by either matrix-assisted laser desorption ionization-time-of-flight-mass spectrometry (MALDI-TOF-MS) or capillary liquid chromatography tandem mass spectrometry (LC-MS/MS).
RESULTS: Analysis by two-dimensional electrophoresis (2DE) established that there were multiple post-translational variants of the majority of the proteins. Hormones, growth factors and bioactive peptides were detected and identified.
CONCLUSIONS: We have identified over 100 protein and peptide components of normal human seminal fluid. Copyright 2004 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15305340     DOI: 10.1002/pros.20089

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  34 in total

1.  Stable-protein Pair Analysis as A Novel Strategy to Identify Proteomic Signatures: Application To Seminal Plasma From Infertile Patients.

Authors:  Ferran Barrachina; Meritxell Jodar; David Delgado-Dueñas; Ada Soler-Ventura; Josep Maria Estanyol; Carme Mallofré; Josep Lluís Ballescà; Rafael Oliva
Journal:  Mol Cell Proteomics       Date:  2018-12-05       Impact factor: 5.911

2.  Analysis of a regulatory protein isolated from the bovine prostate.

Authors:  P A Nazarova; V P Yamskova; M S Krasnov; I A Yamskov
Journal:  Dokl Biol Sci       Date:  2005 Nov-Dec

3.  Male reproductive proteins and reproductive outcomes.

Authors:  Roberta B Ness; David A Grainger
Journal:  Am J Obstet Gynecol       Date:  2008-01-14       Impact factor: 8.661

Review 4.  Peptides in seminal fluid and their role in infertility: a potential role for opiorphin inhibition of neutral endopeptidase activity as a clinically relevant modulator of sperm motility: a review.

Authors:  Jayme S Bosler; Kelvin P Davies; Genevieve S Neal-Perry
Journal:  Reprod Sci       Date:  2014-05-22       Impact factor: 3.060

5.  Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples.

Authors:  Akos Végvári; Melinda Rezeli; Jari Häkkinen; Carina Sihlbom; Elisabet Carlsohn; Johan Malm; Hans Lilja; Thomas Laurell; György Marko-Varga
Journal:  J Proteomics       Date:  2011-06-23       Impact factor: 4.044

Review 6.  Identification and function of proteolysis regulators in seminal fluid.

Authors:  Brooke A Laflamme; Mariana F Wolfner
Journal:  Mol Reprod Dev       Date:  2012-12-04       Impact factor: 2.609

Review 7.  The use of genomics, proteomics, and metabolomics in identifying biomarkers of male infertility.

Authors:  Jason R Kovac; Alexander W Pastuszak; Dolores J Lamb
Journal:  Fertil Steril       Date:  2013-02-15       Impact factor: 7.329

Review 8.  Seminal plasma as a diagnostic fluid for male reproductive system disorders.

Authors:  Andrei P Drabovich; Punit Saraon; Keith Jarvi; Eleftherios P Diamandis
Journal:  Nat Rev Urol       Date:  2014-04-08       Impact factor: 14.432

9.  Trypsin-like proteolytic contamination of commercially available psa purified from human seminal fluid.

Authors:  Michael L Manning; Maya Kostova; Simon A Williams; Samuel R Denmeade
Journal:  Prostate       Date:  2011-12-28       Impact factor: 4.104

Review 10.  The Use of Proteomics in Assisted Reproduction.

Authors:  Ioanna Kosteria; Athanasios K Anagnostopoulos; Christina Kanaka-Gantenbein; George P Chrousos; George T Tsangaris
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.